Clinical Trials on Carcinoma, Renal Cell in Hong Kong
Total 1054 results
-
AstraZenecaCompletedCancer | Advanced Hepatocellular CarcinomaKorea, Republic of, Hong Kong
-
Chinese University of Hong KongCompletedMental Health Wellness 1 | Mental Well-being | Mental Health IssueHong Kong
-
Hoffmann-La RocheCompleted
-
Y-mAbs TherapeuticsTerminatedNeuroblastoma RecurrentKorea, Republic of, Hong Kong
-
Servier Bio-Innovation LLCRegeneron Pharmaceuticals; Institut de Recherches Internationales ServierNot yet recruitingNon-small Cell Lung Cancer (NSCLC)Hong Kong, United States, Australia
-
GlaxoSmithKlineCompletedCarcinoma, HepatocellularTaiwan, Thailand, Hong Kong
-
GlaxoSmithKlineCompletedCarcinoma, HepatocellularTaiwan, United States, Hong Kong
-
Novartis PharmaceuticalsTerminatedHepatocellular CarcinomaHong Kong, Taiwan, Thailand
-
University of WashingtonNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Cervical Undifferentiated Carcinoma | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage... and other conditionsUnited States, Hong Kong, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Squamous Cell Carcinoma of the Nasopharynx | Stage IV Squamous Cell Carcinoma of the NasopharynxUnited States, Singapore, China
-
Light Sciences OncologyCompletedCarcinoma, Hepatocellular | Liver NeoplasmsTaiwan, Hong Kong, Singapore
-
Coventry UniversityThe University of Hong Kong; Radboud University, Donders Institute for Brain... and other collaboratorsNot yet recruitingDepression | Pain | Stress | Anxiety | Mental Well-being | Prosocial Behavior | Attention | Empathy | ForgivenessChina, India
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
Toray Industries, IncAstellas Pharma IncCompletedChronic Renal Failure | Glomerular Disease | NephrosclerosisChina, Hong Kong, Taiwan, Malaysia, Japan, Korea, Republic of, Thailand
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedLung CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
Center Trials & TreatmentNo longer availableGlioblastoma Multiforme | Melanoma (Skin) | Melanoma Recurrent | Glioma of Brain | Glioblastoma by Gene Expression ProfileHong Kong, Belarus, Tajikistan, Uzbekistan
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
Hoffmann-La RocheCompletedNasopharyngeal CancerHong Kong, Thailand, Indonesia, Taiwan, Malaysia
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaHong Kong, Korea, Republic of, Singapore
-
Novartis PharmaceuticalsTerminatedAdvanced Hepatocellular Carcinoma With c-MET DysregulationChina, Hong Kong, Thailand, Singapore
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
National University Hospital, SingaporeJanssen, LP; International Myeloma FoundationUnknownRelapse and / or Refractory MyelomaSingapore, Hong Kong, Taiwan, Korea, Republic of
-
Dong-A UniversityCompletedMicroinvasive Squamous Cell CarcinomaKorea, Republic of
-
AstraZenecaIonis Pharmaceuticals, Inc.CompletedAdvanced Adult Hepatocellular Carcinoma | Hepatocellular Carcinoma MetastaticKorea, Republic of, Taiwan, Hong Kong, Japan
-
National University Hospital, SingaporeCelgene; International Myeloma Foundation; The Australasian Leukaemia & Lymphoma...UnknownRelapsed and/or Refractory Multiple MyelomaSingapore, Hong Kong, Korea, Republic of, Taiwan
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellUnited States, Taiwan, Belgium, Israel, Australia, Hong Kong, China, Czech Republic
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
Alentis Therapeutics AGRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States, Hong Kong, Singapore, Spain, Canada, Italy
-
Novartis PharmaceuticalsTerminatedColorectal Cancer | Gastrointestinal Stromal Tumors | Non-small Cell Lung Carcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal SCCUnited States, Germany, Spain, Singapore, Australia, Hong Kong, Belgium, Japan, China
-
Ligand PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Hong Kong, Taiwan
-
Novartis PharmaceuticalsCompletedEsophageal Squamous Cell CarcinomaTaiwan, Spain, Canada, Singapore, Hong Kong, Korea, Republic of, Belgium, United Kingdom, United States
-
Novartis PharmaceuticalsWithdrawnAdvanced Hepatocellular CarcinomaGermany, Australia, Hong Kong, Switzerland, Spain, France, United States
-
Cullinan Oncology, LLCNational Cancer Institute (NCI)TerminatedNasopharyngeal Carcinoma | Nasopharyngeal CancerFrance, Singapore, United States, China, Hong Kong
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerTaiwan, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerHong Kong, Taiwan, Philippines, China, Thailand, Indonesia, Australia, Korea, Republic of
-
National Cancer Institute (NCI)CompletedRecurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Salivary Gland Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Nasopharyngeal Keratinizing Squamous... and other conditionsUnited States, China
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
Dong-A UniversityCompletedBowen's DiseaseKorea, Republic of
-
Novartis PharmaceuticalsCompletedNeoplasms | Kidney Neoplasms | Breast Neoplasms | Pancreatic Neuroendocine Neoplasms (pNETs)France, Germany, United States, Netherlands, Italy, Spain, United Kingdom, Hong Kong, Hungary
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularUnited States, Hong Kong, Taiwan, Singapore
-
Progen PharmaceuticalsTerminatedCancer | Hepatocellular Carcinoma | Primary Liver Cancer | Liver Cancer | HepatomaHong Kong, Singapore, United States, Australia, Canada, Italy, Malaysia, Spain, Taiwan, Thailand
-
Y-mAbs TherapeuticsWithdrawnNeuroblastomaKorea, Republic of, Singapore, Hong Kong, Russian Federation
-
Novartis PharmaceuticalsRecruitingCarcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Carcinoma, Ovarian Epithelial | Mesothelioma | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Neoplasms | Anal Cancer | Cutaneous Melanoma | Esophagogastric Cancer | Carcinoma, Thymic | High Microsatellite...Italy, Spain, Singapore, Germany, Taiwan, Japan, Canada, Hong Kong, United States
-
Arbutus Biopharma CorporationCompletedHepatocellular Carcinoma | Hepatoma | Liver Cancer, Adult | Liver Cell Carcinoma, AdultUnited States, Taiwan, Singapore, China, Canada, Korea, Republic of
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Triple Negative Breast Cancer | Microsatellite Stable Colorectal CancerUnited States, Taiwan, Spain, Germany, Japan, Hong Kong
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerChina, Hong Kong, Russian Federation, Singapore